Stanley Teleka

Doctoral Student, MPH, MB.BS

Research

Project 1
Metabolic factors and bladder cancer risk in Me-Can study 2.0 The study includes ca. 470,000 individuals, of which approximately 3200 incident bladder cancer cases in Metabolic Syndrome and Cancer (Me-Can) project,
which includes six cohorts in Sweden, Norway, and Austria. Metabolic factors relate to body mass index (BMI), blood pressure, plasma glucose, triglycerides,
and total cholesterol. These factors are studied both individually and in interaction with smoking associated with bladder cancer risk.
Bladder cancer is studied for all tumors together and separately for muscle invasive and non-muscle invasive tumors

Research

Project 2

Blood pressure and bladder cancer risk in two Malmö cohorts The study includes 60,000 individuals in the Malmo Diet and Cancer Study and Malmö Preventive Medicine which about 700 incident bladder cancer cases.
Genetic analyzes include ca. 48,000 individuals with ca.
500 bladder cancer cases. Blood pressure studied in relation to bladder cancer risk with the traditional analysis of the measured levels of blood pressure,
and with so-called Mendelian randomiseringsanalys where a genetic score of blood pressure studied in relation to bladder cancer risk.
Blood pressure is studied both individually and in interaction with smoking and the NAT2,
a detoxifying agent that catalyze certain carcinogens associated with bladder cancer risk.
Bladder cancer is studied for all tumors together and separately for muscle invasive and non-muscle invasive tumors

Recent research outputs

View All (2)